Given that CD4+ T cells could indirectly modulate virus infection by orchestrating antibody production, enhanced T-cell-mediated immune responses, as shown in W4P-RBD vaccination, can contribute to the production and maintenance of IgG and IgA antibodies with potent neutralizing activity (Figure 5B). This evidence concerns the gene CD79A and viral infectious disease.